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Abstract
Background: Exercise may improve cardiorespiratory fitness in people with schizophrenia, however, possible condition-
specific cardiorespiratory disadvantages, a scarcity of methodologically sound studies, and conflicting results raise questions
about the effect of exercise on maximal oxygen uptake (VO2max) in this group. The primary aim of this study, therefore, was
to investigate the effect of high-intensity interval training on VO2max in people with schizophrenia. Second, we sought to
determine whether the intervention would have an effect on general physical activity (PA) level and body composition.
Methods: Eighty-two patients with schizophrenia were randomly assigned to supervised high-intensity interval training or
computer gaming skills training, performed twice a week for 12weeks. Oxygen uptake was measured directly, during a
maximum exercise session on a treadmill. PA level were assessed using ActiGraph accelerometer, and body composition
was assessed by bioelectrical impedance. Differences between groups were assessed by analysis of variance using a
univariate general linear model.
Results: There were no significant differences between the groups on any of the cardiorespiratory variables neither at
baseline nor after the program. There were also no significant within-group differences in any of the cardiorespiratory
fitness variables between the baseline and post-program time points, despite that 61% of the participants performing high-
intensity interval training showed a significant increase in workload on the treadmill. However, 47% of the participants in
the high-intensity interval training group had a≥ 5% increase in VO2max. Participants supervised by mental health care
providers with PA competence (e.g. rehabilitation center staff, sport scientist, physical trainer) had a much larger increase in
VO2max compared to participants supervised by mental health workers without such competence, and when adding PA
competence to the model, the intervention group increased VO2max significantly compared to the comparison group. The
intervention had no significant effect on PA level or body composition.
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Conclusions: The intervention did not improve VO2max, PA level or body composition but succeeded in increasing
workload on the treadmill. With regard to VO2max, approximately half of the patients may be considered responders.
Trial registration: ClinicalTrials.gov; NCT02205684, registered July 2014,
Keywords: Schizophrenia, RCT, Exercise, Maximal oxygen uptake, Physical activity
Background
The effects of schizophrenia on years of potential life
lost and life expectancy are substantial [1]. People with
schizophrenia have an elevated risk of developing cardio-
vascular diseases (CVD) and a significantly increased risk
of death from CVD compared to the general population,
which may, to a large extent, explain the shortened life
expectancy in this patient group [2–4]. The prevalence
discrepancy in somatic disorders, such as CVD [2] and
type 2 diabetes (T2D) [5, 6], between people with schizo-
phrenia and the general population, is not fully under-
stood. It is likely due to a complex interplay among
many factors, such as the metabolic side effects of anti-
psychotics (i.e., leading to overweight) [7], tobacco
smoking [8], alcohol misuse [9], poor dietary habits [10],
low help-seeking behavior [11] and a possible genetic
susceptibility to cardiovascular disease in people with
schizophrenia [12, 13]. Additionally, low levels of moderate
and vigorous intensity physical activity (MVPA) [14–16],
excessive amounts of sedentary time [16, 17] (defined as
any waking behavior characterized by an energy expend-
iture ≤1.5 metabolic equivalents while in a seated or reclin-
ing posture [18]), and poor cardiorespiratory fitness (CRF)
levels [15, 19], have been recognized as potentially import-
ant factors for the high prevalence of somatic disorders
[20–22].
In the general population, CRF levels have been linked
to both genetic [23] and behavioral factors, including
physical activity (PA) [24] and exercise [25]. The ob-
served low PA level [15] and lack of exercise in people
with schizophrenia may, therefore, be important factors
explaining the poor CRF level. However, the picture may
be more complex in this patient group. It has been
proposed that, in addition to adverse metabolic effects,
antipsychotic drugs also have adverse effects on the car-
diovascular system (i.e., antagonistic activity at alpha-
adrenergic receptors) [26–28]. It is also proposed that a
high prevalence of chronotropic incompetence (attenu-
ated heart rate response to exercise) [26, 29], reduced
activity of the efferent vagal system [30] and mitochon-
drial dysfunction [31, 32] may be condition-specific fac-
tors related to their CRF level.
Because people with schizophrenia in general have low
CRF level, which is closely linked to CVD and mortality,
supporting this patient group to exercise and thereby in-
creasing their CRF level seems appropriate. However,
the abovementioned cardiovascular disadvantages may
potentially negatively impact the effect of exercise on the
cardiorespiratory system. Although one meta-analysis
[33] and two systematic reviews [19, 34] all concluded
that exercise significantly improves CRF levels in schizo-
phrenia, most of the included studies had methodo-
logical shortcomings. For example, of the eight studies
included in these papers, four did not include a control
group [35–38], and one was nonrandomized [39]. Fur-
thermore, the number of participants was generally very
low, ranging from five to 16 in the exercise group. Fi-
nally, none of the studies controlled for physical effort
using the respiratory exchange ratio (RER) value or any
other possible confounder. Although criteria for what
constitutes a valid CRF test were often given, it was not
reported how many participants passed the criteria for a
valid test. The only study with a relatively large sample
size and a relatively rigorous design and analysis found a
significant difference between the groups, but this was
due to a decline in the CRF of the control group partici-
pants rather than increased CRF in the participants of
the exercise group [40].
The positive effect of exercise, especially high-intensity
interval training (HIIT), on CRF and health is well estab-
lished in studies of the general population [41] and
across several diseases-specific states [42]. Given the
abovementioned possible cardiorespiratory disadvantages
(e.g. chronotropic incompetence and mitochondrial dys-
function) in people with schizophrenia and conflicting
results from the few studies conducted, the effect of ex-
ercise on CRF in this patient group is unclear. The pri-
mary aim of this study, therefore, was to investigate the
effect of HIIT on CRF in people with schizophrenia. Sec-
ond, we aimed to test whether partaking in an HIIT ex-
ercise regime in combination with applying key
constructs from social cognitive theory (e.g., self-efficacy
and social support for PA) would have an effect on the
general PA level; third, we sought to test whether the




This study is based on data from the Effects of Physical
Activity in Psychosis study (EPHAPS) (ClinicalTrials.gov,
registration number NCT02205684). The study was
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approved by the Regional Ethics Committee for Medical
Research (2014/372). The methods used in EPHAPS
have been described in detail elsewhere [43]. Briefly, the
study was designed as a randomized, controlled, parallel-
group, observer-blinded clinical trial with the aim of in-
vestigating the effects of a supervised high-intensity
interval training program on maximal oxygen uptake
(VO2max), cognitive function and psychiatric symptom
load in outpatients with schizophrenia.
Recruitment and participants
Participants were recruited from August 2014 through
May 2017 from catchment-area-based and publicly
funded outpatient psychiatric clinics in Vestfold County,
Norway. Patients aged 18–67 years old, IQ ≥ 70, who
understood and spoke a Scandinavian language and
fulfilled the criteria in The Diagnostic and Statistical
Manual of Mental Disorders (5th ed.; DSM-5) [44] for
schizophrenia spectrum disorder (schizophrenia, schi-
zoaffective disorder, and schizophreniform disorder)
were eligible for the study. Patients who were pregnant
or had physical contraindications to exercise were ex-
cluded. Initial information about the study was given to
eligible patients by clinical staff in the outpatient clinic
or in primary health services. Written consent was ob-
tained from those eligible patients who understood the
nature of the research and were willing to participate.
Eighty-three participants signed the informed consent
form and were included in the study. One participant
withdrew from the study after baseline testing but before
randomization. A scheme of the flow of participants
through the trial is presented in Fig. 1.
Randomization and stratification
After the baseline assessments, the participants were
randomly assigned to either the HIIT group (intervention
group) or the computer gaming skills group (comparison
group). A computerized random number generator was
utilized to produce the allocation sequence. Equal distri-
bution of CRF between the two groups of participants was
ensured by stratification around the expected median of
baseline VO2max scores. By varying the size of the stratifi-
cation blocks, we kept each treatment assignment unpre-
dictable. A designated project coordinator, who was not
involved in recruitment or measurement sessions, admin-
istered the group assignments using the method of
concealed envelopes. The randomization process was per-
formed at a site remote from where the intervention took
place.
Interventions
The HIIT sessions and the computer gaming took place
at different locations and the participants in the two
groups did not have any contact with each other. The
same personnel, which were employed in the outpatient
clinics and dedicated to the project throughout the
intervention period, carried out supervision of the par-
ticipants in both groups. The time spent with activities
was the same in both groups, as was the time spent with
the intervention staff. A specific time schedule was
followed by the staff to ensure that each session in the
exercise and comparison group lasted 45min. In
addition to the sessions, most of the participants in both
groups were accompanied by a member of the interven-
tion staff during transportation to and from the sessions.
Both groups also received treatment as usual.
The exercise sessions consisted of supervised walking/
running on a treadmill twice a week for 12 weeks. The
exercise sessions were led by two teams each consisting
of two persons. The two different teams had different
background and experience with regard to exercise and
physical activity. Half of the participants were supervised
by mental health care providers with PA competence
(rehabilitation center staff with relevant PA education),
and the other half was led by mental health professionals
without PA competence. Each session had the following
structure: an 8-min warm up, followed by 4 × 4 min in-
tervals at 85–95% of maximum heart rate, with active
pauses consisting of 3 min of walking/running at ap-
proximately 70% of maximum heart rate, and a 5 min
cool-down period at the end. Heart rate was measured
and controlled continuously throughout the exercise ses-
sion by the intervention staff to ensure that the partici-
pants’ intervals and active pauses were performed with
the desired intensity. Peak heart rate from the VO2max
test was used to calculate prescribed exercise intensity.
Additionally, the intervention staff attempted to increase
the participants’ motivation for PA. Although delivered
in informal settings, during transportation, and before
and after sessions, the motivational work was individual-
ized, structured and theory-based. Key constructs from
social cognitive theory [45] were applied: opportunities
to perform PA, social support for PA, confidence to en-
gage in PA, expected benefits and costs of performing
PA, knowledge and skill to perform PA, and personal
goal setting.
Participants in the comparison group took part in ses-
sions in which they performed computer-simulated sports
activities, such as tennis, baseball, golf and bowling, on a
Nintendo Wii Sports console (Nintendo, Kyoto, Japan).
Physiological responses (i.e., oxygen consumption, cardiac
output, metabolic rate) to Nintendo Wii tennis and baseball
have been shown to be lower than the response to brisk
treadmill walking when tested in bouts of 10min [46].
Measurements
Cardiorespiratory fitness, or maximal oxygen uptake
(VO2max), was assessed through a maximum exercise test
Andersen et al. BMC Psychiatry          (2020) 20:425 Page 3 of 12
on a treadmill (Woodway, Würzburg, Germany), by
physical activity professionals, before and after the 12-
week intervention. We used a modified Balke protocol
[47], where speed was held constant at 5 km∙h− 1 and the
inclination angle was increased by one degree every mi-
nute until exhaustion within 6–12min. Gas exchange
was continuously sampled in a mixing chamber every
30 s by having the subjects breathe into a Hans Rudolph
two-way breathing valve (2700 series, Hans Rudolph
Inc., Kansas City, USA). The breathing valve was con-
nected to a Jaeger Oxycon Pro (Erich Jaeger GmbH,
Hoechberg, Germany), which was used to analyze the
oxygen and carbon dioxide content. The Jaeger Oxycon
Pro has been found to be both valid and reliable [48].
The test result was included in the current study if the
respiratory exchange ratio (RER) (i.e., physical strain)
was ≥1.00 [49]. Heart rate was recorded with an RCX3
heart monitor from Polar (Polar Electro Oy, Kempele,
Finland). The oxygen pulse (ml∙beat− 1) was calculated
by dividing VO2max (mL∙min
− 1) by the maximal heart
rate (beats∙ min− 1) and used as an estimate of the heart’s
stroke volume.
Pulmonary function was measured by maximal expira-
tory flow volume curves (MasterScreen Pneumo spirom-
eter; CareFusion, Hochberg, Germany) according to
current guidelines set by the American Thoracic Society
and The European Respiratory Society in 2005 [50]. The
items measured were forced vital capacity (FVC), forced
expiratory volume in 1 s (FEV1), FEV1/FVC and maximal
expiratory flow at 50% of FVC (MEF 50%). Maximal vol-
untary ventilation (MVV) was estimated as FEV1
multiplied by 35. In addition, breathing reserve (%) was
calculated using the following equation: ([MVV -
VEmax]/MVV) × 100, where VEmax is the maximal mi-
nute ventilation during the exercise test. Predicted spir-
ometry values were according to [51]. Obstructive lung
disease was identified by FEV1/FVC < 0.7 [52].
Physical activity was assessed using the ActiGraph
GT3X+ accelerometer (ActiGraph, LLC, Pensacola, FL,
USA) in vertical axis collection mode. The participants
were instructed to wear the accelerometer over the left
hip while awake, except during water-based activities
(e.g., showering, swimming), for four consecutive days.
The epoch length (sample interval) was set to 10 s. All
data were reintegrated into 60 s epochs and further
processed and analyzed using specialized accelerometer
analytical software (Kinesoft, version 3.3.80, Saskatch-
ewan, Canada). Analyses were restricted to participants
who wore the accelerometer for a minimum of 10 h per
day [53] for at least two days (including one weekday
and one weekend day) [54–56]. To identify different in-
tensities of PA, we applied count thresholds correspond-
ing to the energy cost of the given intensity, where
sedentary time was defined as all activity < 100 counts
per minute (CPM) [57], a threshold that corresponds
with sitting, reclining, or lying down. Light intensity PA
was defined as 100–2019 CPM, moderate as 2020–5998
CPM, and vigorous as CPM ≥ 5999 [58].
Body composition was estimated barefooted in light
clothing by bioelectrical impedance (MC-980 MA;
Tanita Corp., Tokyo, Japan). Assessment of body com-
position was performed around noon, approximately
Fig. 1 EPHAPS trial flowchart
Andersen et al. BMC Psychiatry          (2020) 20:425 Page 4 of 12
three hours after a light breakfast, at both time points.
Weight was measured to the nearest 0.5 kg in light
clothing and no shoes using a SECA electronic scale
(SECA model 767; Hamburg, Germany). Height was
measured without shoes on a portable stadiometer
(Harpenden; Holtain, Crymych, Wales) and rounded
to the nearest 0.5 cm.
Data on education, employment, marital status and
smoking were obtained through a clinical interview and
the use of hospital charts. Positive and negative psych-
otic symptom levels, as well as the total general symp-
tom level were assessed with the Positive and Negative
Syndrome Scale (PANSS) [59]. Information on current
medication was acquired through patients’ interviews
and the use of medical records and information from
the general practitioners. Defined daily doses (DDD)
were calculated in accordance with guidelines from the
World Health Organization Collaborating Center for
Drug Statistics Methodology (http://www.whocc.no/
atcdd). The DDD is the assumed average maintenance
dose per day for a drug used for its main indication on
adults and provide a fixed unit of measurement inde-
pendent of dosage form, providing a rough estimate of
pharmaceutical drugs consumption.
Statistical analysis
All statistical analyses were performed using SPSS (Stat-
istical Package for the Social Sciences for Windows, ver-
sion 24, IBM, Inc., Chicago, IL, USA). Descriptive data
are presented as proportions, means, and standard devia-
tions (SDs) with 95% confidence intervals (CIs) where
appropriate. Within- and between-group differences in
interval data were evaluated by t-tests (independent t-
tests and paired t-tests). Differences between groups
were assessed by analysis of variance using a univariate
general linear model. Baseline CRF variables (dependent
variables) were adjusted for RER, age and sex (covari-
ates). Post-program CRF variables were adjusted for
post-program RER, age and sex. After the completion of
our trial, Firth et al. (2017) showed in a meta-analysis
that exercise studies that were supervised by PA profes-
sionals (e.g. rehabilitation center staff, sport scientist,
physical trainer) were more effective [60]. Our study was
not designed or powered to look at staff competence,
but present explorative analysis of time x group x staff
PA competence, using a three-way repeated measures
ANOVA. A univariate general linear model was used to
assess differences between the groups PA level (CPM,
sedentary time, light intensity PA, moderate intensity
PA, vigorous intensity PA and steps per day). Acceler-
ometer wear time was considered a potential confounder
and included in the analysis. Differences between the
groups in terms of education level, employment and
marital status were assessed using chi-squared tests.
Treadmill speed and/or inclination on interval number
three in weeks four and 12 was analyzed to estimate pro-
gress or work capacity. For work capacity, week four was
set as baseline measure to avoid a learning effect on the
treadmill. All significance tests were two-sided.
Results
Table 1 displays the relevant demographic and clinical
information for both groups. Except for three participants,
all were using antipsychotic medication. Sixty-two partici-
pants used second-generation antipsychotics (SGA) and
six used first-generation antipsychotics (FGA). Of the 25
participants receiving ≥ two different antipsychotic drugs,
11 received a combination of FGA and SGA. There were
no significant differences between groups with respect to
type of antipsychotic medication and the main metabolic
risk profile of these drugs [61, 62]. Defined daily doses of
antipsychotics was slightly higher in the intervention
group compared to the comparison group (mean diff 0.4,
95% CI 0.0, 0.8; P = 0.04). There were no other statistical
differences between the groups at baseline. In addition,
regular antidepressants, mood stabilizing medication and
anxiolytics were received by 19, 12 and 11 participants,
respectively.
Of the 43 participants randomized to HIIT, 34 (79%)
attended the post-program measurements and 21 (49%)
had a valid VO2max test (Fig. 1). Of the 39 participants
randomized to the comparison group, 37 (95%) attended
Table 1 Baseline sociodemographic and clinical characteristics
for both groups
Characteristics Intervention
group (n = 43)
Comparison
group (n = 39)
Female (%) 39 38
Age (years) 36 (14) 37 (13)
PANSS
Total 68 (16) 63 (16)
Negative 19 (7) 17 (6)
Positive 15 (5) 14 (5)
Duration of illness (years) 15 (11) 15 (13)
Antipsychotics (DDD)* 1.8 (1.0) 1.3 (0.7)
Smokers (%) 62 71
Education level (%)
Primary school 44 41
High school 37 28
College/university 18 30
Employed at least 50% of full time (%) 11 10
Married or living with a partner (%) 14 13
Presented values are the mean ± SD if not specified otherwise. DDD, defined
daily doses. PANSS; Positive and Negative Syndrome Scale. * Significant
difference between groups (P ≤ 0.05)
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the post-program measurements and 26 (67%) had a
valid VO2max test (Fig. 1).
There were no differences between groups in any of
the cardiorespiratory variables either at baseline or after
the program (Table 2). There were no within-group dif-
ferences in any of the cardiorespiratory fitness variables
between the baseline and post-program time points.
However, 47% of the participants in the intervention
group and 27% in the comparison group had a ≥ 5% in-
crease in VO2max (mL∙kg
− 1∙min− 1). We classified partici-
pants with ≥1 metabolic equivalent (MET) increase in
VO2max (mL∙kg
− 1∙min− 1) as responders [63]. The re-
sponders had, adjusted for gender, significantly lower
VO2max at baseline (mean diff. -8.4 mL∙kg
− 1∙min− 1, 95%
CI -15, − 1.4; P = 0.02) were 7.7 (14, 0.4; P = 0.03) years
older and had higher BMI (4.0 kg∙m− 2, 0.5, 7.6; P = 0.02),
waist circumference (11 cm 21, 1.4; P = 0.02) and visceral
fat mass (5.5 kg, 8.5, 2.6; P < 0.0001) than non-
responders (<5% increase in VO2max (mL∙kg
− 1∙min− 1).
No other differences were found between responders
and non-responders, including exercise performance
(number of sessions, number of intervals, number of in-
tervals above 85% of maximum heart rate).
The HIIT participants led by mental health workers
with PA competence had a significantly larger increase
in CRF (2.4 mL∙kg− 1∙min− 1 ± 4.5) compared to the HIIT
participants led by mental health workers without such
competence (− 2.2 mL∙kg− 1∙min− 1 ± 4.7), with a mean
difference of 4.7 mL∙kg− 1∙min− 1 (95% CI = 1.2, 8,1; P =
0.010). There were no significant differences in number
of sessions, number of intervals or number of intervals
performed at ≥85% of maximal heart rate between the
two HIIT groups. So, when controlling for staff PA com-
petence there was a significant difference in CRF be-
tween the intervention group and the comparison group
(F [1, 60] = 11.4, p = 0.001; Wilk’s Λ = 0.84, partial ƞ2 =
0.16).
The average number of sessions conducted was 18.1 ± 4.3
and 19.2 ± 2.0 (mean diff − 1.1, 95% CI -2.6, 0.4; P = 0.16) in
the intervention and comparison groups, respectively, and
participation ranged from 6 to 24 sessions in the interven-
tion group and 15 to 24 in the comparison group. In the
intervention group, 83% of the participants attended ≥60%
of the sessions, and 54% attended ≥80% of the sessions. In
the comparison group, 100 and 70% attended ≥60% and ≥
80% of the sessions, respectively. There was no significant
difference in any of the cardiorespiratory variables after we
excluded those who participated in either <60% or <80% of
the sessions. Of a possible total of 96 intervals, the exercise
group conducted, on average, 69 ± 19 intervals (range 16 to
96). 39.9% of the intervals was performed ≥85% of maximal
heart rate. There was no significant correlation between
VO2max and the number of intervals performed. However,
there was a significant correlation (r = 0.43; P = 0.14) be-
tween number of intervals performed at ≥85% of maximum
heart rate and change in VO2max.
Table 2 Between-group difference in cardiorespiratory responses to maximal exercise at baseline and post-program
Intervention group Comparison group
N Mean (SD) N Mean (SD) Mean diff 95% CI P
VO2max (L·min
− 1) Baseline 34 2.7 (0.7) 27 2.5 (0.9) 0.05 0.2, −0.3 0.7
Post-program 20 2.7 (0.9) 26 2.6 (0.9) 0.1 0.3, − 0.1 0.3
VO2max (mL∙kg
−1∙min−1) Baseline 34 32.1 (11) 27 31.1 (11) 0.9 3.6, −5.5 0.7
Post-program 21 30.8 (11) 26 31.1 (11) −1.8 −4.4, 0.8 0.17
VO2max (mL∙kgFFM
−1∙min− 1) Baseline 34 44.8 (12) 27 42.6 (12) 0.2 5.5, −4.9 0.9
Post-program 20 43.4 (12) 26 43.2 (12) 1.7 5.6, −2.1 0.3
RER (VCO2/VO2) Baseline 34 1.09 (0.05) 27 1.09 (0.06) 0.00 0.02, −0.04 0.5
Post-program 21 1.10 (0.07) 26 1.08 (0.06) 0.01 0.05, −0.02 0.3
Maximal heart rate (beats·min− 1) Baseline 34 174 (22) 27 170 (17) 0.4 8, −7 0.9
Post-program 20 173 (20) 26 169 (13) 1.8 5.4, −1.7 0.3
Ventilation (L∙min− 1) Baseline 29 94 (29) 22 84 (30) 2.0 −16, 12 0.7
Post-program 21 88 (27) 24 85 (25) 3.8 −13, 5 0.4
Oxygen pulse (mL∙beats− 1) Baseline 34 15.5 (3.9) 27 14.5 (4.7) 0.4 2.3, −1.3 0.5
Post-program 19 16.0 (4.3) 25 15.2 (5.1) 0.6 2.0, −0.7 0.3
Resting heart rate (beats∙min− 1) Baseline 34 75 (12) 27 75 (16) 0.9 8, −6 0.7
Post-program 21 75 (13) 24 72 (14) 0.4 7, −6 0.8
Heart rate reserve (beats∙min−1) Baseline 34 98 (25) 27 94 (26) 0.5 10, −11 0.9
Post-program 19 97 (21) 23 97 (23) 1.2 8.8, −6.4 0.7
Presented values are the mean ± SD. VO2max, peak oxygen uptake. FFM, fat-free mass. RER, respiratory exchange ratio. CI, confidence interval
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Participants in the exercise group showed significant
improvements in work capacity, shown by both im-
proved treadmill running speed and inclination from
week four to week 12 (Table 3). Sixty-one percent im-
proved running speed and/or inclination. Eighty-six per-
cent of the responders (≥ 1MET increase in VO2max),
compared to 53% of the non-responders (< 1 MET in-
crease in VO2max) improved work capacity (P = 0.50).
Ninety percent of the participants achieved ≥85% of
maximum heart rate during both exercise sessions.
There were no differences in pulmonary function be-
tween groups or within groups at either time point
(Table 4). Baseline VO2max (mL∙kg
− 1∙min− 1) had a mod-
erate correlation with FVC (r = 0.31, P = 0.01), FEV1 (r =
0.35, P < 0.001) and MEF50 (r = 0.40, P < 0.01). Twelve
percent had < 80% of predicted FEV1, and 10.5% scored
below 70% on the FEV1/FVC ratio (FEV1%). Thirty per-
cent had a low breathing reserve (< 15%), whereas 32%
had a high breathing reserve (> 40%) that may suggest
pulmonary or cardiovascular limitations, respectively, for
exercise performance [64].
There were no significant differences between the
groups in PA level or sedentary time at either time point
(Table 5). No statistical changes were found within
groups in any of the PA or sedentary variables. There
were no associations between changes in VO2max and
any of the PA variables.
There were no significant differences in body compos-
ition between groups at either time point (Table 6). No
statistically significant changes were found within groups
in any of the body composition variables.
Discussion
This is the largest study to date investigating the effects
of HIIT in schizophrenia, compared with with low inten-
sity game-based exercise. We managed in the current
study to recruit patients with schizophrenia into a highly
physically demanding exercise program. Most of the par-
ticipants adhered to the exercise protocol in terms of
both the number and the intensity of the sessions. The
intervention group did not significantly improve their
VO2max, and no significant difference between the
groups was found after the program, even when we ex-
cluded those that did not adhere to the exercise proto-
col. However, approximately half of the participants
responded satisfactory (increased VO2max with ≥1 MET)
to the intervention. The intervention group, especially
the responders, did increase their work capacity, as
shown by the increased workload on the treadmill (i.e.
speed and/or inclination). When controlling for PA
competence among intervention staff in explorative ana-
lysis, the intervention group significantly increased
VO2max compared to the comparison group. The inter-
vention did not have any effect on the PA level, seden-
tary behavior or body composition of the participants.
Although there were no significant within- or
between-group differences, almost half of the partici-
pants in the intervention group had 5 % or greater in-
crease in VO2max. The participants who responded (i.e.,
with increased VO2max) to the exercise regime did not
differ from the non-responders with respect to the quan-
tity or quality of training conducted, but we did find a
correlation between change in VO2max and number of
intervals performed at ≥85% of maximum heart rate.
Importantly, the responders had a lower VO2max and
were heavier and older than the non-responder at
baseline, and thus an especially important target
group within this population. Our results may imply
that people with schizophrenia can respond as ex-
pected to HIIT but that there may be more non-
responders in this patient group than in the general
population [65]. If our results hold true, we need to
further investigate why some patients do not respond
to HIIT to see if measures can be taken (e.g., medica-
tion) and perhaps to a larger extent treating under-
lying pulmonary and cardiovascular diseases affecting
normal physiological adaptation to exercise.
Regarding the effect of HIIT on VO2max in this patient
group, the literature is not consistent. The EPHAPS
study reinforces the uncertainty of whether this patient
group as a whole responds as expected to this type of
training. As mentioned in the introduction, there might
be condition-specific and medication-related factors hin-
dering their ability to adapt normally to HIIT and thus
Table 3 Work capacity measured at interval number three in weeks 4 and 12 in the group performing high-intensity interval
training
Mean (SD) Mean diff 95% CI P
Treadmill speed (km/h) Week 4 6.1 (2.2) 0.5 0.2, 0.9 0.002
Week 12 6.7 (2.8)
Treadmill inclination (%) Week 4 4.1 (2.8) 1.6 0.2, 2.9 0.02
Week 12 5.7 (5.1)
Heart rate (beats/min) Week 4 155 (21) 3.9 0.8, 7.1 0.01
Week 12 159 (22)
N = 36. Presented values are the mean ± SD. CI, confidence interval
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Table 4 Between-group differences in pulmonary function at baseline and post-program
Intervention group Comparison group
N Mean (SD) N Mean (SD) Mean diff 95% CI P
FVC (L) Baseline 43 4.4 (1.3) 39 4.2 (1.1) 0.2 −0.3, 0.7 0.4
Post-program 32 4.3 (1.3) 37 4.2 (1.1) 0.0 −0.5, 0.6 0.7
FVC % pred (%) Baseline 100 (20) 96 (15) 3.3 −4.9, 11.6 0.4
Post-program 99 (17) 98 (14) −1.3 −8.5, 5.9 0.7
FEV1 (L) Baseline 43 3.4 (1.0) 39 3.3 (1.0) 0.1 −0.3, 0.6 0.5
Post-program 32 3.3 (1.0) 37 3.1 (0.9) 0.1 −0.3, 0.6 0.4
FEV1 pred (%) Baseline 93 (16) 90 (19) 2.7 −56, 11.1 0.5
Post-program 93 (18) 89 (17) 1.8 −5.8, 9.6 0.6
FEV1/FVC (%) Baseline 42 77 (11) 37 77 (10) −0.1 −4.9, 4.6 0.9
Post-program 32 78 (8) 37 75 (11) 2.5 −2.2, 7.3 0.2
FEV1/FVC pred (%) Baseline 95 (13) 95 (12) −0.3 −6.2, 5.6 0.9
Post-program 96 (9) 93 (14) 3.7 − 2.2, 9.7 0.2
MEF50 (L· s
−1) Baseline 42 3.9 (1.5) 37 3.9 (1.4) 0.0 −0.5, 0.7 0.8
Post-program 32 3.8 (1.6) 37 3.4 (1.3) 0.4 −0.3, 1.1 0.2
MEF50 pred (%) Baseline 78 (25) 78 (25) 0.2 −11.6, 12.1 0.9
Post-program 78 (27) 70 (25) 8.0 −5.0, 21 0.2
MVV (L) Baseline 40 120 (37) 37 114 (36) 5.7 −11, 22 0.5
Post-program 32 118 (37) 35 110 (31) 7.8 −9, 24 0.3
BR (%) Baseline 37 26 (18) 32 22 (26) 4.2 −7, 15 0.4
Post-program 25 21 (20) 27 20 (23) 0.8 −11, 13 0.8
Presented values are the mean ± SD. SD, standard deviation. CI, confidence interval. Pred, predicted. FVC, forced vital capacity. FEV1, forced expiratory
volume in 1 s. MEF 50%, maximal expiratory flow 50%. MVV, maximal voluntary ventilation. BR, breathing reserve
Table 5 Between-group differences in physical activity level and sedentary time at baseline and post-program
Intervention group Comparison group
N Mean (SD) N Mean (SD) Mean diff 95% CI P
Number of valid days Baseline 35 3.4 (1.0) 35 3.4 (1.2) 0.0 −0.5, 0.6 0.8
Post-program 23 3.1 (1.1) 25 3.1 (1.0) −0.0 − 0.6, 0.6 0.9
Wear time (min∙day−1) Baseline 35 10.3 (2.9) 35 10.7 (3.1) −0.3 −1.9, 1.1 0.6
Post-program 23 10.6 (2.3) 25 10.8 (2.8) −0.2 −1.7, 1.3 0.7
Total PA level (CPM) Baseline 33 220 (91) 34 255 (157) −35 −97, 26 0.25
Post-program 22 246 (154) 25 281 (198) −34 − 121, 52 0.4
Light PA (min∙day− 1) Baseline 35 202 (90) 35 205 (91) −2.6 −40, 34 0.8
Post-program 23 226 (92) 25 199 (78) 27 −13, 68 0.18
Moderate PA (min∙day− 1) Baseline 35 19 (12) 35 26 (23) −7.0 −16, 2.6 0.15
Post-program 23 24 (18) 25 21 (21) 2.7 −0.5, 11 0.5
Vigorous PA (min∙day−1) Baseline 35 0.6 (2.1) 35 1.4 (3.7) −0.8 −2.3, 0.7 0.3
Post-program 23 1.9 (3.6) 25 2.1 (9.9) −0.1 −2.7, 2.3 0.8
MVPA (min∙day−1) Baseline 35 20 (12) 35 28 (24) −7.8 −17, 2.0 0.11
Post-program 23 26 (20) 25 23 (26) 2.7 −0.6, 11 0.5
Steps per day Baseline 33 3984 (1519) 34 4532 (3262) − 548 − 1713, 617 0.3
Post-program 22 4568 (2509) 25 4620 (2825) −52 − 1474, 1369 0.9
Sedentary time (hours∙day−1) Baseline 35 8.2 (1.6) 35 8.2 (1.6) −0.0 −0.7, 0.7 0.9
Post-program 23 8.3 (1.6) 25 8.1 (1.6) 0.1 −0.8, 1.1 0.7
Presented values are the mean ± SD. PA, physical activity. CPM, counts per minute. MVPA, moderate to vigorous physical activity. CI, confidence interval
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preventing the physiological adaptations necessary to in-
crease VO2max.
One of the possible benefits of HIIT is an improve-
ment of VO2max, and thus involves several organs.
VO2max is primarily limited by the ability of the cardio-
respiratory system to deliver oxygen to the exercising
muscle [66]. This means that, theoretically, one would
need to make adaptations related to the heart’s stroke
volume in order to increase VO2max. Thus, one possible
explanation for the lack of effect on VO2max, although
measured indirectly, might be the fact that the partici-
pants’ stroke volume did not increase. There might also
be other plausible reasons for the lack of effect, such as
the high prevalence of abnormal breathing reserve (indi-
cating pulmonary or heart disease) and a relatively high
prevalence of cardiovascular and respiratory disease.
Furthermore, in a systematic review including 35 studies
using population-based samples, 97 genes were found to
predict VO2max trainability, and lower responders had
fewer positive response alleles than higher responders
[67]. Thus, one could imagine that people with schizo-
phrenia have fewer positive response alleles than other
populations, or that potential epigenetic modifiers, such
as medication, sleep, and body fat, influence gene ex-
pression and molecular function, thereby influencing
VO2max training response [67].
As discussed above, there might be several reasons for
the lack of significant effect on VO2max. The most plaus-
ible reason however, may coincide with the exercise re-
gime per se. The total exercise volume (number of
sessions per week, number of intervals per session, in-
tensity) and/or the number of participants adhering to
the protocol might have been insufficient to obtain a sig-
nificant effect on VO2max. The significant correlation be-
tween number of intervals performed ≥85% of maximal
heart rate and improvements in VO2max supports the
view that the exercise intensity, on a group level, might
have been too low on too many intervals. The exercise
protocol in the current study, however, is widely used,
with success, in different populations and should have
been sufficient to obtain positive results [41, 42], more-
over, most of the participants adhered to the strictly su-
pervised sessions, both in terms of number of intervals
and intensity. Furthermore, a recently published study
on people with schizophrenia, using exactly the same ex-
ercise protocol, with fewer participants than in our
study, did find a significant effect on VO2max in the exer-
cise group compared to a control group [68].
There was a markedly difference in response to the
intervention with regard to CRF improvement within
the HIIT group. The subgroup supervised by mental
health care providers with PA competence had a signifi-
cant increase in CRF, while the subgroup supervised by
mental health care providers without such competence
did not. We did not find any differences with regard to
adherence to the exercise protocol between the two sub-
groups, but this may be due to lack of statistical power
and/or validity of training diaries. These analyses were
done post hoc, based on the findings by Firth et al.
(2017), which found that the effect of exercise was larger
Table 6 Between-group difference in weight, BMI, waist circumference and body composition at baseline and post-program
Intervention group Comparison group
N Mean (SD) N Mean (SD) Mean diff 95% CI P
Weight (kg) Baseline 43 90.3 (21) 39 88.6 (24) 1.7 −8.6, 12 0.7
Post-program 32 91.8 (21.3) 37 88.3 (25) 0.6 −2.2, 1.0 0.4
BMI (kg/m2) Baseline 43 29.8 (5.8) 39 29.3 (6.3) 0.4 −2.2, 3.1 0.7
Post-program 32 30.3 (5.8) 37 29.3 (6.7) 0.1 0.6, −0.4 0.6
Waist circumference (cm) Baseline 41 105 (16) 37 104 (18) 0.6 7, −8 0.8
Post-program 33 107 (15) 34 103 (18) 1.3 3, −0.7 0.19
Percent fat Baseline 43 30.5 (8.1) 39 29.3 (10.6) 1.1 3, −5 0.5
Post-program 32 30.7 (8.5) 37 29.7 (11.1) 0.0 0.9, −0.8 0.9
Fat mass (kg) Baseline 43 28.1 (10.8) 39 27.5 (15.5) 0.6 5, −6 0.8
Post-program 32 28.8 (11.2) 37 27.9 (16.1) 0.2 1.3, −0.8 0.6
Muscle mass (kg) Baseline 43 59.1 (14.0) 39 58.0 (12.7) 1.0 4, −6 0.7
Post-program 32 59.8 (13.2) 37 57.4 (12.8) 0.3 1.2, −0.4 0.3
Fat-free mass (kg) Baseline 43 62.2 (14.7) 39 61.0 (13.2) 1.2 4, −7 0.7
Post-program 32 62.9 (13.8) 37 60.4 (13.4) 0.2 1.1, −0.6 0.5
Visceral fat (kg) Baseline 41 9.7 (4.8) 33 8.3 (5.0) 1.4 0.8, −3 0.2
Post-program 30 9.4 (4.5) 36 9.2 (6.4) 0.1 0.6, −0.3 0.5
Presented values are the mean ± SD. BMI, body mass index. CI, confidence interval
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among patients supervised by PA professionals [60]. Half
of our participants were supervised by PA professionals
and when adding PA competence to the model there
was a significant increase in CRF in the intervention
group compared to the comparison group. We do not
have data to explain this result and can only speculate if
our main results would have been different if all partici-
pants were supervised by health care providers with PA
competence.
The intervention did not change the participants’ total
PA level. Performing HIIT twice a week was probably
enough of a challenge for the participants, and a “light-
touch” PA component designed to increase motivation
for PA was not grasped. Furthermore, the lack of im-
proved body composition is in line with previous re-
search [33]. An improvement in body composition
would probably demand both an increased total PA level
and an adapted diet [69].
The EPHAPS study has a number of strengths. First,
we were able to recruit a large number of patients into a
methodologically rigorous RCT involving a highly phys-
ical demanding exercise protocol, designed to increase
VO2max, and a sound comparison condition. The broad
recruitment strategies and wide inclusion criteria mark-
edly strengthen the generalizability of the results. Sec-
ond, each exercise session was carefully supervised by
skilled personnel, who most likely contributed consider-
ably to the number of patients who fulfilled the relatively
demanding exercise requirements (i.e., number of ses-
sions and intensity of intervals). Other major strengths
of this study included direct measurement of VO2max
and stricter conditions than previous research for what
constitutes a valid result, objective measurement of PA
levels, and reliable measurement of body composition
and pulmonary function. One major weakness affecting
the power of the study was the high number of invalid
VO2max tests. Although most of the patients exerted
maximum effort during the VO2max test, many did not
manage to achieve a respiratory exchange ratio of ≥1.00
and hence failed to attain a valid test result.
Conclusions
The intervention did not improve maximal oxygen up-
take, physical activity level or body composition but suc-
ceeded in increasing work capacity. With regard to
maximal oxygen uptake, approximately half of the par-
ticipants may be considered responders. Although most
of the participants adhered to the exercise protocol, the
correlation between number of intervals performed
≥85% of maximal heart rate with improvement in
VO2max, leaves some uncertainty of whether an even
stricter intensity-supervision would have yielded differ-
ent results. Further investigation is needed to determine
why so many did not respond to the exercise regime and
to identify the consequences of non-response. HIIT is a
demanding exercise protocol, especially for patients with
severe mental disorders, who may benefit from supervi-
sion of health care providers with competence on phys-
ical activity rather than health care providers without
such competence.
Abbreviations
CVD: cardiovascular disease; T2D: type 2 diabetes; MVPA: moderate- and
vigorous intensity physical activity; CRF: cardiorespiratory fitness; PA: physical
activity; RER: respiratory exchange ratio; HIIT: high-intensity interval training;
EPHAPS: effects of physical activity in psychosis study; VO2max: maximal
oxygen uptake; FVC: forced vital capacity; FEV1: forced expiratory volume in
1 s; MEF 50%: maximal expiratory flow 50%; MVV: maximal voluntary
ventilation; DDD: defined daily doses; SGA: second generation antipsychotics;
FGA: first generation antipsychotics; MET: metabolic equivalent; PANS
S: positive and negative syndrome scale; FFM: fat free mass; CI: confidence
interval; SD: standard deviation; BR: breathing reserve; CPM: counts per
minute; BMI: body mass index
Acknowledgments
The authors would like to give thanks to all participants. The authors also
thanks Ole-Jakob Bredrup, Helge Bjune, Jan-Freddy Hovland, Bjørn-Einar
Oscarsen, Camilla Lahn-Johannessen and Ellen Gurine Færvik for conducting
the measurements and delivering the intervention.
Authors’ contributions
Conceptualization: EA, JAE, JE, GBK, TTB, TLH, EWM and TS. Data curation: EA,
JAE, JE, GBK and TS. Formal analysis: EA, JAE, GBK and TS. Investigation: EA,
JAE, JE, GBK, TTB, TLH, EWM and TS. Writing – original draft: EA. Writing –
review and editing: EA, JAE, JE, GBK, TTB, TLH, EWM and TS. All authors have
read and approved the manuscript.
Funding
The main study (EPHAPS) has received funding from Vestfold Hospital Trust,
South-Eastern Norway Regional Health Authority, Norwegian Extra Foundation
for Health and Rehabilitation through EXTRA funds, Norwegian Research
network in Severe Mental Illness (NORSMI), NORMENT/KG Jebsen Center for
Psychosis Research, Torgeir Lindvik’s Trust, and Civitan International. The funders
had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Availability of data and materials
Data can be accessed upon request.
Ethics approval and consent to participate
The study was approved by the Regional Ethics Committee for Medical
Research, REC south east Norway (2014/372). Initial information about the
study was given to eligible patients by clinical staff in the outpatient clinic or
in primary health services. Written consent was obtained from those eligible





The authors declare that they have no competing interests.
Author details
1Faculty of Humanities, Sports and Educational Science, University of
South-Eastern Norway, PO box 235, 3603 Kongsberg, Horten, Norway.
2Division of Mental Health and Addiction, Vestfold Hospital Trust, Tønsberg,
Norway. 3Department of Psychology, University of Oslo, Oslo, Norway. 4Clinic
Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
5Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 6Department
of Sports Medicine, Norwegian School of Sports Sciences, Oslo, Norway.
Andersen et al. BMC Psychiatry          (2020) 20:425 Page 10 of 12
Received: 2 April 2020 Accepted: 19 August 2020
References
1. Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost
and life expectancy in schizophrenia: a systematic review and meta-analysis.
Lancet Psychiatry. 2017;4(4):295–301.
2. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P,
et al. Prevalence, incidence and mortality from cardiovascular disease in
patients with pooled and specific severe mental illness: a large-scale meta-
analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry.
2017;16(2):163–80.
3. Nielsen RE, Uggerby AS, Jensen SO, McGrath JJ. Increasing mortality gap for
patients diagnosed with schizophrenia over the last three decades--a
Danish nationwide study from 1980 to 2010. Schizophr Res. 2013;146(1–3):
22–7.
4. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from
preventable physical illness in psychiatric patients in Western Australia:
retrospective analysis of population based registers. BMJ. 2013;346:f2539.
5. Stubbs B, Vancampfort D, De Hert M, Mitchell AJ. The prevalence and
predictors of type two diabetes mellitus in people with schizophrenia: a
systematic review and comparative meta-analysis. Acta Psychiatr Scand.
2015;132(2):144–57.
6. Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al.
Diabetes mellitus in people with schizophrenia, bipolar disorder and major
depressive disorder: a systematic review and large scale meta-analysis.
World Psychiatry. 2016;15(2):166–74.
7. Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA,
et al. Head-to-head comparisons of metabolic side effects of second
generation antipsychotics in the treatment of schizophrenia: a systematic
review and meta-analysis. Schizophr Res. 2010;123(2–3):225–33.
8. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH.
Smoking and mental illness: a population-based prevalence study. JAMA.
2000;284(20):2606–10.
9. Hjorthoj C, Ostergaard ML, Benros ME, Toftdahl NG, Erlangsen A, Andersen
JT, et al. Association between alcohol and substance use disorders and all-
cause and cause-specific mortality in schizophrenia, bipolar disorder, and
unipolar depression: a nationwide, prospective, register-based study. Lancet
Psychiatry. 2015;2(9):801–8.
10. Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The
dietary pattern of patients with schizophrenia: a systematic review. J
Psychiatr Res. 2013;47(2):197–207.
11. Fleury MJ, Grenier G, Bamvita JM, Caron J. Professional service utilisation
among patients with severe mental disorders. BMC Health Serv Res. 2010;
10:141.
12. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS,
O'Donovan MC, et al. Improved detection of common variants associated
with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk
factors. Am J Hum Genet. 2013;92(2):197–209.
13. Malan-Muller S, Kilian S, van den Heuvel LL, Bardien S, Asmal L, Warnich L,
et al. A systematic review of genetic variants associated with metabolic
syndrome in patients with schizophrenia. Schizophr Res. 2016;170(1):1–17.
14. Stubbs B, Firth J, Berry A, Schuch FB, Rosenbaum S, Gaughran F, et al. How
much physical activity do people with schizophrenia engage in? A
systematic review, comparative meta-analysis and meta-regression.
Schizophr Res. 2016;176(2–3):431–40.
15. Andersen E, Holmen TL, Egeland J. Martinsen EW. Bang-Kittilsen G, et al.
Physical activity pattern and cardiorespiratory fitness in individuals with
schizophrenia compared with a population-based sample. Schizophr Res:
Bigseth TT; 2018.
16. Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M,
et al. Sedentary behavior and physical activity levels in people with
schizophrenia, bipolar disorder and major depressive disorder: a global
systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–15.
17. Janney CA, Ganguli R, Richardson CR, Holleman RG, Tang G, Cauley JA, et al.
Sedentary behavior and psychiatric symptoms in overweight and obese
adults with schizophrenia and schizoaffective disorders (WAIST study).
Schizophr Res. 2013;145(1–3):63–8.
18. Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, Latimer-Cheung
AE, et al. Sedentary behavior research network (SBRN) - terminology
consensus project process and outcome. Int J Behav Nutr Phys Act. 2017;
14(1):75.
19. Vancampfort D, Rosenbaum S, Probst M, Soundy A, Mitchell AJ, De Hert M,
et al. Promotion of cardiorespiratory fitness in schizophrenia: a clinical
overview and meta-analysis. Acta Psychiatr Scand. 2015;132(2):131–43.
20. Vancampfort D, De Hert M, Sweers K, De Herdt A, Detraux J, Probst M.
Diabetes, physical activity participation and exercise capacity in patients
with schizophrenia. Psychiatry Clin Neurosci. 2013;67(6):451–6.
21. Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C. The effect of
dietary and physical activity pattern on metabolic profile in individuals with
schizophrenia: a cross-sectional study. Compr Psychiatry. 2012;53(7):1028–33.
22. Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people
with and without comorbid mental illness and substance misuse: systematic
review of comparative studies. Br J Psychiatry. 2009;194(6):491–9.
23. Bouchard C, An P, Rice T, Skinner JS, Wilmore JH, Gagnon J, et al. Familial
aggregation of VO(2max) response to exercise training: results from the
HERITAGE Family Study. J Appl Physiol (1985). 1999;87(3):1003–8.
24. Nokes N. Relationship between physical activity and aerobic fitness. J Sports
Med Phys Fitness. 2009;49(2):136–41.
25. Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of
Exercise Training on Cardiorespiratory Fitness and Biomarkers of
Cardiometabolic Health: A Systematic Review and Meta-Analysis of
Randomized Controlled Trials. J Am Heart Assoc. 2015;4(7).
26. Kim DD, Lang DJ, Procyshyn RM, Woodward ML, Kaufman K, White RF, et al.
Reduced cardiovascular fitness associated with exposure to clozapine in
individuals with chronic schizophrenia. Psychiatry Res. 2018;262:28–33.
27. Piascik MT, Perez DM. Alpha1-adrenergic receptors: new insights and
directions. J Pharmacol Exp Ther. 2001;298(2):403–10.
28. Hermesh H, Shiloh R, Epstein Y, Manaim H, Weizman A, Munitz H. Heat
intolerance in patients with chronic schizophrenia maintained with
antipsychotic drugs. Am J Psychiatry. 2000;157(8):1327–9.
29. Herbsleb M, Schumann A, Malchow B. Puta C. Gabriel HW, et al.
Chronotropic incompetence of the heart is associated with exercise
intolerance in patients with schizophrenia. Schizophr Res: Schulze PC; 2018.
30. Ostermann S, Herbsleb M, Schulz S, Donath L, Berger S, Eisentrager D, et al.
Exercise reveals the interrelation of physical fitness, inflammatory response,
psychopathology, and autonomic function in patients with schizophrenia.
Schizophr Bull. 2013;39(5):1139–49.
31. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. Mitochondrial
DNA (mtDNA) and schizophrenia. Eur Psychiatry. 2011;26(1):45–56.
32. Rosenfeld M, Brenner-Lavie H, Ari SG, Kavushansky A, Ben-Shachar D.
Perturbation in mitochondrial network dynamics and in complex I dependent
cellular respiration in schizophrenia. Biol Psychiatry. 2011;69(10):980–8.
33. Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-
analysis of exercise interventions in schizophrenia patients. Psychol Med.
2015;45(7):1343–61.
34. Vancampfort D, Rosenbaum S, Ward PB, Stubbs B. Exercise improves
cardiorespiratory fitness in people with schizophrenia: a systematic review
and meta-analysis. Schizophr Res. 2015;169(1–3):453–7.
35. Strassnig MT, Newcomer JW, Harvey PD. Exercise improves physical capacity
in obese patients with schizophrenia: pilot study. Schizophr Res. 2012;
141(2–3):284–5.
36. Bredin SS, Warburton DE, Lang DJ. The health benefits and challenges of
exercise training in persons living with schizophrenia: a pilot study. Brain
Sci. 2013;3(2):821–48.
37. Rosenbaum S, Lagopoulos J, Curtis J, Taylor L, Watkins A, Barry BK, et al.
Aerobic exercise intervention in young people with schizophrenia spectrum
disorders; improved fitness with no change in hippocampal volume.
Psychiatry Res. 2015;232(2):200–1.
38. Dodd KJ, Duffy S, Stewart JA, Impey J, Taylor N. A small group aerobic exercise
programme that reduces body weight is feasible in adults with severe chronic
schizophrenia: a pilot study. Disabil Rehabil. 2011;33(13–14):1222–9.
39. Heggelund J, Nilsberg GE, Hoff J, Morken G, Helgerud J. Effects of high
aerobic intensity training in patients with schizophrenia: a controlled trial.
Nord J Psychiatry. 2011;65(4):269–75.
40. Scheewe TW, Takken T, Kahn RS, Cahn W, Backx FJ. Effects of exercise
therapy on cardiorespiratory fitness in patients with schizophrenia. Med Sci
Sports Exerc. 2012;44(10):1834–42.
41. Cassidy S, Thoma C, Houghton D, Trenell MI. High-intensity interval training:
a review of its impact on glucose control and cardiometabolic health.
Diabetologia. 2017;60(1):7–23.
Andersen et al. BMC Psychiatry          (2020) 20:425 Page 11 of 12
42. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in
patients with lifestyle-induced cardiometabolic disease: a systematic review
and meta-analysis. Br J Sports Med. 2014;48(16):1227–34.
43. Engh JA, Andersen E, Holmen TL, Martinsen EW, Mordal J, Morken G, et al.
Effects of high-intensity aerobic exercise on psychotic symptoms and
neurocognition in outpatients with schizophrenia: study protocol for a
randomized controlled trial. Trials. 2015;16:557.
44. AmericanPsychiatricAssociation. Diagnostic and statistical manual of mental
disorders (DSM-5®). American Psychiatric Pub. 2013.
45. Bandura A. Health promotion by social cognitive means. Health Educ Behav.
2004;31(2):143–64.
46. Willems M, Bond T. Comparison of physiological and metabolic responses
to playing Nintendo Wii sports and brisk treadmill walking. J Human Kinet.
2009;22:43–50.
47. Balke B, Ware RW. An experimental study of physical fitness of air force
personnel. U S Armed Forces Med J. 1959;10(6):675–88.
48. Carter J, Jeukendrup AE. Validity and reliability of three commercially
available breath-by-breath respiratory systems. Eur J Appl Physiol. 2002;86(5):
435–41.
49. Howley ET, Bassett DR Jr, Welch HG. Criteria for maximal oxygen uptake:
review and commentary. Med Sci Sports Exerc. 1995;27(9):1292–301.
50. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.
Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.
51. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-
ethnic reference values for spirometry for the 3-95-yr age range: the global
lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.
52. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS.
Global strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease. NHLBI/WHO global initiative for chronic
obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care
Med. 2001;163(5):1256–76.
53. Wolff-Hughes DL, Bassett DR, Fitzhugh EC. Population-referenced
percentiles for waist-worn accelerometer-derived total activity counts in U.S.
youth: 2003–2006 NHANES. PLoS One. 2014;9(12):e115915.
54. Hart TL, Swartz AM, Cashin SE, Strath SJ. How many days of monitoring
predict physical activity and sedentary behaviour in older adults? Int J
Behav Nutr Phys Act. 2011;8:62.
55. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr. Sources of
variance in daily physical activity levels as measured by an accelerometer.
Med Sci Sports Exerc. 2002;34(8):1376–81.
56. Rowe DA, Kemble CD, Robinson TS, Mahar MT. Daily walking in older adults:
day-to-day variability and criterion-referenced validity of total daily step
counts. J Phys Act Health. 2007;4(4):434–46.
57. Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR,
et al. Amount of time spent in sedentary behaviors in the United States,
2003-2004. Am J Epidemiol. 2008;167(7):875–81.
58. Troiano RP. A timely meeting: objective measurement of physical activity.
Med Sci Sports Exerc. 2005;37(11 Suppl):S487–9.
59. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale
(PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
60. Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, et al.
Aerobic exercise improves cognitive functioning in people with
schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2017;
43(3):546–56.
61. Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics,
antidepressants and mood stabilizers on risk for physical diseases in people
with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;
14(2):119–36.
62. Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB,
et al. Risk of metabolic syndrome and its components in people with
schizophrenia and related psychotic disorders, bipolar disorder and major
depressive disorder: a systematic review and meta-analysis. World
Psychiatry. 2015;14(3):339–47.
63. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise
capacity and mortality among men referred for exercise testing. N Engl J
Med. 2002;346(11):793–801.
64. Wasserman K, Hansen J, Sue D, Stringer W, Whipp B. Principles of exercise
testing and interpretation. 5 ed: Lippincott Williams & Wilkins; 2012.
65. Bouchard C, Rankinen T. Individual differences in response to regular
physical activity. Med Sci Sports Exerc. 2001;33(6 Suppl):S446–51; discussion
S52–3.
66. Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and
determinants of endurance performance. Med Sci Sports Exerc. 2000;32(1):
70–84.
67. Williams CJ, Williams MG, Eynon N, Ashton KJ, Little JP, Wisloff U, et al.
Genes to predict VO2max trainability: a systematic review. BMC Genomics.
2017;18(Suppl 8):831.
68. Brobakken MF, Nygard M, Guzey IC, Morken G, Reitan SK, Heggelund J, et al.
Aerobic interval training in standard treatment of out-patients with
schizophrenia: a randomized controlled trial. Acta Psychiatr Scand. 2019;
140(6):498–507.
69. Beavers KM, Beavers DP, Nesbit BA, Ambrosius WT, Marsh AP, Nicklas BJ,
et al. Effect of an 18-month physical activity and weight loss intervention
on body composition in overweight and obese older adults. Obesity (Silver
Spring). 2014;22(2):325–31.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Andersen et al. BMC Psychiatry          (2020) 20:425 Page 12 of 12
